|
LM22A-4
- 英文名称：LM22A-4
- 品牌：WYTSCI
- 产地：进口
- 型号：1MG
- 货号：WT-AY-B10298
- cas：37988-18-4
- 价格： ￥1/mg
- 发布日期： 2025-04-10
- 更新日期： 2025-05-23
产品详请
| 产地 | 进口 |
| 品牌 | WYTSCI |
| 货号 | WT-AY-B10298 |
| 用途 | 科研检测 |
| 英文名称 | LM22A-4 |
| 包装规格 | 1MG |
| CAS编号 | 37988-18-4 |
| 别名 | LM22A-4 |
| 纯度 | 98+% |
| 分子式 | |
| 是否进口 | 是 |
纯度:98% by TLC,;NMR (Conforms)
分子式:C15H21N3O6
分子量:339.35
溶剂:DMSO (50 mg/ml) Water (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TrkB agonist
Function / Pharmacology:Small molecule BDNF mimetic displaying neurotrophhic activity. Partial agonist at TRKB and activates TRKB signaling. In in vitro models of neurodegenerative disease, it prevented neuronal degeneration with equal efficacy to that of BDNF. After in vivo administraton, it caused hippocampal and striatal TrkB activation in mice and improved motor learning after traumatic brain injury in rats1. Improves respiratory function in a mouse models of Rett syndrome2.
分子式:C15H21N3O6
分子量:339.35
溶剂:DMSO (50 mg/ml) Water (50 mg/ml)
性状:White solid
存储:-20°C
Activity (short version):TrkB agonist
Function / Pharmacology:Small molecule BDNF mimetic displaying neurotrophhic activity. Partial agonist at TRKB and activates TRKB signaling. In in vitro models of neurodegenerative disease, it prevented neuronal degeneration with equal efficacy to that of BDNF. After in vivo administraton, it caused hippocampal and striatal TrkB activation in mice and improved motor learning after traumatic brain injury in rats1. Improves respiratory function in a mouse models of Rett syndrome2.
